FDA Watch: First NGS Residual Cancer Detection Test Wins Approval

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

From - Laboratory Industry Report
As the year winds down, diagnostic deals aren't as plentiful. Nevertheless, there have been some significant transactions. Here's a recap of…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here